Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Ivanprokov's Profile
Displaying 1-4 of 4 result(s).
IPIX Innovation Pharmaceuticals Inc
05/23/2013 4:04:09 PM
Don't be so cryptic. I have no time
IPIX Innovation Pharmaceuticals Inc
05/23/2013 4:03:29 PM
Don't be so cryptic.  Are you impl
IPIX Innovation Pharmaceuticals Inc
05/23/2013 3:37:00 PM
Don't congratulate him too much. Ac
IPIX Innovation Pharmaceuticals Inc
05/23/2013 3:32:11 PM
Synaptic

Recent Articles

  • Skanska's New Engineering Facility Contract Worth $240 Million
  • Aalberts Shares Buyback Program: Key Updates & Insights
  • PST Group's Shareholder Meeting Draft Resolutions Explained
  • MAG Silver Reveals Management Circular for Shareholders' Meeting
  • Explore the New GL52RP: An Advanced LoRaWAN Asset Tracker
  • Exclusive Discount on KIWI Design's K4 Head Strap for VR Enthusiasts
  • Tarkett's Recent Announcement on Public Buy-Out Offer Details
  • Insights on Tarkett Participation's Information Document Release
  • Idorsia Welcomes Dr. Srishti Gupta as New CEO for Growth
  • dsm-firmenich’s Strategic Share Repurchase Plan Update
  • Exciting Public Offering of Bigbank's Subordinated Bonds
  • Molecular Partners Focuses on Growth and Operational Efficiency
  • Virtu Financial Partners with Limina to Enhance TradeOPS Platform
  • Optimizing AI Innovation: Elliptic Labs and Ceva Partnership
  • Sangfor's Innovation Recognized by Frost & Sullivan in APAC
  • Echosens and Boehringer Ingelheim Join Forces for MASH Care
  • Innovative Indoor Ecosystem Technology Revolutionizes Home Comfort
  • Perseus Mining’s Nyanzaga Project Receives Technical Report
  • Queclink Unveils Innovative GL52RP for Enhanced Asset Monitoring
  • Explore the Versatile Shinjuku Duffel Bag for All Occasions
  • Embracing the Outdoors: TVA's Commitment to Recreation
  • European Consumers Adapt to Economic Challenges and Changing Tastes
  • Abbisko Therapeutics Achieves Major Milestone for Pimicotinib
  • XCMG Launches Innovative Training Initiative for Global Talent
  • Tredence: A Leader in AI Innovation and Growth Recognition
  • Celebrating Tredence's Fourth Year as Databricks Award Winner
  • Tredence Celebrated as Leading AI Growth Partner in 2025
  • Tredence Dominates Industry with Databricks Award Achievements
  • Anteris Technologies Welcomes New Board Members for Growth
  • Gerdau S.A. Unveils Results of Completed Tender Offer
  • Exciting Win: Indian Player Scores Porsche During Lottery Event
  • Sony Semiconductor Solutions Unveils Advanced SPAD Depth Sensor
  • Perseus Mining Preview: Five-Year Outlook on Gold Production
  • Aura Minerals Unveils Promising Economic Assessment for Era Dorada
  • Carlton Precious Expands Private Placement for Exploration Gains
  • Brand Engagement Network's Impressive Q1 2025 Results Revealed
  • Uniti Group Inc. Secures $600 Million in Senior Notes Offering
  • Goliath Resources Enhances Private Placement Terms for Investors
  • Edelson Lechtzin LLP Initiates Investigation of Humana Inc.
  • Hidrovias International Finance Releases Tender Offer Results
  • Brian B. Su Joins High-Trend International Group as Director
  • Transforming Prisons: A New Era with Joshua Smith's Leadership
  • CURE Auto Insurance Recognized Among Top U.S. Insurers for 2025
  • Lovelytics Celebrates Major Awards at Databricks 2025 Event
  • Vestis Corporation Investors: Join Class Action for Justice
  • CNCF's Kubestronaut Initiative: Giving Wings to Cloud Native Talent
  • iFLYTEK's Triumph: Transforming AI Training with Volcano
  • Virginia Tech Research Highlights Value of Aging Life Care Managers
  • Cibus, Inc. Completes $27.5 Million Offering for Growth
  • Itron's Cyble 5 Module Revolutionizes Water Management in APAC
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site